|
Foresight Biotherapeutics |
|
|
50 West 57th Street (15th Floor)
New York, NY 10019 USA
phone:646 747 9100
fax: 646 365 3256
|
|
| Symbol |
|
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.foresightbiotherapeutics.com
|
|
|
|
 |
| Summary Description |
| Innovative treatments for diseases of the eyes and ears. |
|
| Management |
| Bo Liang, Ph.D., Executive Vice President of Pharmaceutical Development; Joseph Capriotti, M.D., Senior Consultant, Michael Samson, M.D., Consultant |
| |
|
|
|
|
|
| Keywords |
| eye, ear, opthalmology, otolaryngology, adenoviral conjunctivitis, conjunctivitis |
|
|
|
| Description |
|
Foresight Biotherapeutics is a drug development company focused on diseases of the eye and ear. Foresights team of physicians and scientists identify and develop novel treatments for unmet medical needs in ophthalmology and otolaryngology. Their substantial experiences, financial resources and industry knowledge are then used to design the necessary clinical trials and ultimately bring these products to market. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members